z-logo
Premium
Effect of supplementation with an 80:20 cis 9, trans 11 conjugated linoleic acid blend on the human platelet proteome
Author(s) -
Bachmair EvaMaria,
Bots Michiel L.,
Mennen Louise I.,
Kelder Thomas,
Evelo Chris T.,
Horgan Graham W.,
Ford Isobel,
Roos Baukje
Publication year - 2012
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201100763
Subject(s) - conjugated linoleic acid , platelet , proteome , linoleic acid , placebo , platelet activation , medicine , chemistry , biochemistry , fatty acid , endocrinology , biology , pathology , alternative medicine
Scope The dietary fatty acid cis 9, trans 11 conjugated linoleic acid ( cis 9, trans 11 CLA ) has been shown to modify the function of endothelial cells, monocytes, and platelets, all of which are involved in the development of atherosclerosis. Potential mechanisms for the platelet effects have not been assessed previously. In this study, we assessed how supplementation of the diet with an 80:20 cis 9, trans 11 CLA blend affects the platelet proteome. Methods and results In a double‐blind, randomized, placebo‐controlled, parallel‐group trial, 40 overweight but apparently healthy adults received either 4 g per day of cis 9, trans 11 CLA ‐enriched oil or placebo oil, consisting of palm oil and soybean oil, for 3 months. Total platelet proteins were extracted from washed platelets, separated using two‐dimensional gel electrophoresis and differentially regulated protein spots were identified by LC ‐ ESI ‐ MS / MS . Supplementation with the CLA blend, compared with placebo, resulted in significant alterations in levels of 46 spots ( p < 0.05), of which 40 were identified. Network analysis revealed that the majority of these proteins participate in regulation of the cytoskeleton and platelet structure, as well as receptor action, signaling, and focal adhesion. Conclusion The platelet proteomics approach revealed novel insights into regulation of cellular biomarkers of atherogenic and thrombotic pathways by an 80:20 cis 9, trans 11 CLA blend.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom